La catena delle opzioni mostra i dati chiave delle opzioni azionarie di PROCEPT BioRobotics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per PROCEPT BioRobotics..

PROCEPT BioRobotics (NASDAQ:PRCT) Azioni, Catena delle Opzioni

PROCEPT BIOROBOTICS CORP

PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Long Ideas

News

Markets

Media

Trading Ideas

PRCT

Jim Cramer elogia Target per il suo rendimento del 3% e risultati finanziari eccellenti: ecco perché è un&#39;opportunità imperdibile!

Jim Cramer elogia questo titolo: &#34;Il rendimento del 3% è fantastico!&#34;

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics Corp

Press Releases

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Earnings

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

Health Care

General

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

Management

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jupiter Endovascular Closes Oversubscribed Series B Financing, Surpassing $40 Million Target

ISRG

Artivion

Alphatec Holdings

AtriCure

Beta Bionics

Conmed

Enovis

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

Inspire Medical Systems, Inc. Common Stock

Inspire Medical Systems

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Integer Holdings Corporation Common Stock

Integer Holdings

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

LivaNova

LeMaitre Vascular

Masimo

NovoCure

Envista Holdings Corporation Common Stock

Envista Holdings

Omnicell

Pulse Biosciences

QuidelOrtho

SS Innovations International Inc. - Common Stock

SS Innovations

Teleflex

TransMedics Group

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Oppenheimer

Wells Fargo

Piper Sandler

Morgan Stanley

B of A Securities

Comments

PROCEPT BioRobotics

PROCEPT BioRobotics (PRCT) Opzioni

PROCEPT BioRobotics (NASDAQ:PRCT) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO